graphic

...

At the 2016 San Antonio Breast Cancer Symposium, Anne Blaes, M.D., associate professor of medicine at the University of Minnesota, in Minneapolis, and colleagues presented an abstract that focused on the possible cardiovascular effects of aromatase inhibitors (AIs). AIs are a breast cancer treatment used in postmenopausal women instead of or after tamoxifen, for hormone receptor–positive breast cancer. According to the study, extending AI use to 10 years helps reduce the likelihood of recurrence (doi:10.1056/NEJMoa1604700).

Patricia Ganz, M.D., studies quality of life for cancer survivors and how cancer treatments affect patients. She is a professor of health policy and management at the Fielding School of Public Health; professor of medicine at the University of California, Los Angeles; and director of the Center for Cancer Prevention and Control Research at the Jonsson Comprehensive Cancer...

Article PDF first page preview

Article PDF first page preview
Article PDF first page preview
You do not currently have access to this article.